Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02019303 · ClinicalTrials.gov registry record · NA

Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer

A NA study, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
140
Enrollment target

NCT02019303 is a NA study that has completed, run by University of Utah. The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02019303, a NA study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target

Study Summary

To compare accuracy of ultrasound guided fine needle aspiration (FNA) to core needle biopsy (CNB) of ultrasound detected abnormal axillary lymph nodes in patients with newly diagnosed invasive breast cancer or suspected invasive breast cancer. Hypothesis: FNA and CNB have equivalent diagnostic accuracies In order to prove our hypothesis, we will perform FNA and CNB on the same lymph node in each consented patient. The two samples will be evaluated separately by different pathologists blinded to the material in the other sample. The results of the biopsies will be compared to the gold standard (lymph node excision).

Interventions

  • PROCEDURE FNA and Core biopsy

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2014-02
Est. Completion 2019-04-30
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT02019303

The ClinicalTrials.gov registry entry for NCT02019303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which FNA and Core biopsy is the first listed.

NCT02019303 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02019303 about?

NCT02019303 is a clinical study titled "Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer". To compare accuracy of ultrasound guided fine needle aspiration (FNA) to core needle biopsy (CNB) of ultrasound detected abnormal axillary lymph nodes in patients with newly diagnosed invasive breast cancer or suspected invasive breast cancer. Hypothesis: FNA and CNB have equivalent diagnostic accu...

What is the current status of trial NCT02019303?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2014-02. Estimated completion is 2019-04-30.

What interventions are being tested in trial NCT02019303?

The interventions under investigation include: FNA and Core biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT02019303?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.